SIRRIS - QED · SIRRIS Bioprinting: markets and opportunities Grégory Nolens QED –AM in Medical – November 4th 2014

SIRRIS

Bioprinting: markets and opportunities

Grégory Nolens

QED –AM in Medical – November 4th 2014

04/11/2014 © sirris 2014 Charleroi | www.sirris.be | [email protected] | 2

130 experts & high-tech infrastructure

Collective centre of the technology industry • Non profit organization • Industry owned

4,700 industrial interventions (advice, projects, services) •within 1,700 different companies •whose 75% are SME’s •24M EUR turnover

Mission

“Increase the competitiveness of companies of the Agoria sectors through technological innovations”

3

Additive Manufacturing technologies @ Sirris

SIRRIS – One of the largest machine park in EU

• 16 engineers and technicians

• Two locations: Liège (11 p.) and Charleroi (5 p.)

Rapid Prototyping / Tooling / Manufacturing

• Stereolithography (normal & hi-res)

• Paste polymerization for ceramics and metals (Optoform)

• 3D Printing of plaster and metal powder

• Laser sintering of polymeric powder (PA,…): P360 – P390

• Objet Connex 500: bi-material

• Laser sintering of metal powder (parts and mould inserts)

• Electron Beam Melting (Arcam A2)

• 3D Printing of wax (Thermojet)

• Vacuum Casting of Alu, Bronze, Zamak

• Laser Cladding (EasyClad)

• Selective Laser melting (MTT)

• Mcor - paper

• Bi-material FDM system

© sirris 2014 Charleroi | www.sirris.be | [email protected] | 04/11/2014

04/11/2014 4

CASE STUDIES @ SIRRIS

Leading applications of AM in biomedical:

• Personalized/complex devices

• Surgery tools

• In vitro Testing tools

• Communication tools

•Physician to Physician/Patient

•Student/education

© sirris 2014 Charleroi | www.sirris.be | [email protected] |

5

Personalized implants


Poukens – Xilloc - Sirris

6 © sirris 2014 Charleroi | www.sirris.be | [email protected] | 04/11/2014

Newly designed implants – lattice porous structures

Finger prosthesis [UMons, Faculté Polytechnique] Cranial porous implant [SIRRIS-ADD]

04/11/2014 7

Complex implants – mass production

Spinal case studies in ceramic

• Porous scaffolds for Spine surgery

• In vivo testing for bone integration

• France - Belgium collaboration Tech transfer

[Sirris ADD]


04/11/2014 8

Surgery tools – custom cutting

CENG

[VISYOS] [VISYOS]


20-70% surgery time reduction

04/11/2014 9

Surgery tools – custom cutting

CENG

Surgical Cutting Templates – reimbursement problem

Surgical guides not reimbursed, but facts are:

- 1 min. in surgical theatre (estimated): 60€

- Mean of orthopedic surgery duration: 5-12h (18k-44k€)

- Surgical guide can reduce: 20-70% of the duration (TBC)

- Surgical guide cost: 50-300€

- Economy: estimated 3-30k€/surgery


10

Testing tools


Flexible device for in vitro studies (e.g. arteries)

04/11/2014

11

Communication/education tools


[Sirris ADD] [Sirris ADD] [Sirris ADD]

12 © sirris 2014 Charleroi | www.sirris.be | [email protected] | CENG 04/11/2014

The future of bio-manufacturing…not so far away!

13 © sirris 2014 Charleroi | www.sirris.be | [email protected] | CENG 04/11/2014

The future of bio-manufacturing…not so far away!

Anthony Atala – TED – March 2011

14

process of printing biologically relevant materials (such as cells,

tissues, and biodegradable biomaterials) that will accomplish

one or more biological functions

What’s Bioprinting

04/11/2014

+

cells

Bio-glue

3D machine

Tissues Scaffolds

+ cells


http://www.google.com/url?sa=i&rct=j&q=&esrc=s&frm=1&source=images&cd=&cad=rja&docid=cxH1DMQortvt7M&tbnid=ZwgRtPf3evz6tM:&ved=0CAUQjRw&url=http://www.bronzedgoddess.net/product_info.php?products_id=1162&ei=tH_lUfTXO4LOONPtgIgN&bvm=bv.48705608,d.ZWU&psig=AFQjCNFW3GrA6CC31-td7WH9EG5reG-zmw&ust=1374081281698211

http://www.google.com/url?sa=i&source=images&cd=&cad=rja&docid=10PQMU3M_mq11M&tbnid=hWy3pekOaoSwQM:&ved=0CAgQjRwwAA&url=http://www.gizmag.com/3d-bio-printer/13609/&ei=xoHlUbrlMsfXPYbCgMAM&psig=AFQjCNGGQYuzBjhWM8FRWq3HMXx4Xpsk6A&ust=1374081862876612

http://www.google.com/url?sa=i&rct=j&q=&esrc=s&frm=1&source=images&cd=&cad=rja&docid=3mtWJSsTB0ClHM&tbnid=x0QrSPNVN0ApGM:&ved=0CAUQjRw&url=http://galanx-ragalofo.blogspot.com/&ei=MoLlUe2fF4LvPJq4gYgL&bvm=bv.48705608,d.ZWU&psig=AFQjCNHW_RxCUx6l23mKZN99a4qHepoknQ&ust=1374081947300638

04/11/2014 15

Bioprinting – an emerging technology

Bioprinting place in emerging technologies, from the Hype Cycle for Emerging

Technologies 2014- Gartner



Printing cells and biomaterials

http://www.google.com/url?sa=i&rct=j&q=&esrc=s&frm=1&source=images&cd=&cad=rja&docid=PG6biFQqEB_i0M&tbnid=A3VC-_idTQH1EM:&ved=0CAUQjRw&url=http://www.mfoundation.org/blog/2012/02/organovo-named-one-of-fifty-most-innovative-companies-of-2012/&ei=a233UfWrK8iaO8bWgMgN&bvm=bv.49967636,d.ZWU&psig=AFQjCNGmesoN7lbj3KhPqFGCqRXLLojTJQ&ust=1375256270570579

http://www.google.com/url?sa=i&rct=j&q=&esrc=s&frm=1&source=images&cd=&cad=rja&docid=sV71q8JOl-sQUM&tbnid=JHixEv8U19W8qM:&ved=0CAUQjRw&url=http://www.about3dprinters.com/3d-printing-companies.html&ei=Qm73UePfFoO-O621gPAI&bvm=bv.49967636,d.ZWU&psig=AFQjCNGKqYjyFelvFUIaRvxq9NZdyKsCyQ&ust=1375256511808716

Printing cells and biomaterials


EnvisionTech, RegenHU (CH), GESIM (DE), Regenovo

(China)…

3D Bioprinting solutions – customized machines

Printing Cells? Reality

Lot of barriers to raise

Technical, ethical, validation time, standards,…


Bioprinting strategy @ SIRRIS

Step by step approach:

Target most promising and nearest markets

Combine existing knowledge to succeed faster


20

Market approach interest for companies?

04/11/2014

• Applications:

1. Drug/Cosmetic discovery & Assays

2. Cell therapy + Tissue Engineering

3. Bioproduction

4. In vitro diagnostic & research

5. Food


21

Drug/Cosmetic Discovery and Assays

04/11/2014

• Facts: Drug Discovery and Assays

• 90-95% of drugs approved on animal (mouse, rabbit, etc.), was not

for human lot of money lost, ethic problem

• Animal use: 10-100 Mio in US/year

• European Comission banning: FULL on cosmetic (2013), next

pharma ?


22

Drug Discovery and Assays

04/11/2014

• Applications:

• Drug screening w/o animal

& less deviations

Drug X

Disease tissue

Treated tissue

Organovo’s targeted market


Pharmaceutical and

Cosmetic area

(Big companies and

subcontractors)

23

Drug Discovery and Assays

04/11/2014

• Applications:

• Biocompatibility assays w/o animals (ISO)

• Improvement of existing models

Artificial skin Irritation testing


24

Cell Therapy & Tissue engineering

04/11/2014

• Facts: Cell Therapy

Cell therapy industry market

(autologous)


[Markets and Markets]

25


04/11/2014

• Facts: Cell Therapy

High potential for

Small defect repair

But spatial limitations


26


04/11/2014

• Raise cell therapy barrier of Large defect repairing


(= scaffold)

27


04/11/2014

Repairing large defects by combining

+

Stem Cells + Biomaterial Scaffold


= 1st step to bioprinting

+

28

Biotechnolgies & Bioprocess

04/11/2014

• Facts:

• More and more treatments using biomolecules instead of small

drugs: BioPharma / Biological Therapy (protein, peptide, antibody,

etc.) Produced with cells

• Very expensive products: cost reduction through production


[PharmPro]

29

Biotechnolgies & Bioprocess (Bioproduction)

04/11/2014

Application

• Biomolecule production: 2D 3D

• Pure and higher production

• Cost reduction, bigger productions

• Enlarge areas


[university of Virginia]

30

In vitro diagnostic and Research

04/11/2014

• Biomarker

• Biosensors

• Drug kinetic

• Pathogen reaction


biosensor

Blood brain barrier

//upload.wikimedia.org/wikipedia/commons/1/12/Blood_vessels_brain_english.jpg

31

Food & Agriculture

04/11/2014

• New food process?

Focus on food player with Life Science approach:

biomaterial ( e.g. Tissue engineering)


Standards

Medical Device (MD)

MD Directive Regulation proposal

General MD standards (ISO 13485, 10993, …)

Specific standards for applications/material (e.g. ISO

13175 bone filling with Ca-P)

Faster and easier to label than Drugs


Magic Scaffold ------

Synthetic non-active

implant scaffold

Standards

Advanced therapy medicinal products – ATMP

Regulation 1394/2007

Drug like procedure

long clinical procedure (6-10 years, +post market)

heavy process constrains


Magic Cells

------

Standards


Magic Tissue

------

+

? ATMP Incubating cells

+ scaffold

Standards


Magic Cells

------

Magic Scaffold ------

Combined

during

surgery

ATMP

MD

Conclusion

04/11/2014 36 © sirris 2014 Charleroi | www.sirris.be | [email protected] |

Print biomaterial add cells

Print « exotic » biomaterial

validate it add cells

Print biomaterial and cells

Suggested steps to Bioprinting

innovation

Time to market

Bioprinting R&D players in Europe – few


…and others…

http://www.google.com/url?sa=i&rct=j&q=&esrc=s&frm=1&source=images&cd=&cad=rja&docid=zb3LM3dC1-SnKM&tbnid=WG4Cb3I3ugyTOM:&ved=0CAUQjRw&url=http://www.filkfreiberg.de/en/&ei=wmvAUcX7HeGQ0QXUo4DoCw&bvm=bv.47883778,d.d2k&psig=AFQjCNGS3MY9dWHOF9OSeJOlCwmrGbJ_rg&ust=1371651388198460

http://www.google.com/url?sa=i&rct=j&q=&esrc=s&frm=1&source=images&cd=&cad=rja&docid=zb3LM3dC1-SnKM&tbnid=WG4Cb3I3ugyTOM:&ved=0CAUQjRw&url=http://www.filkfreiberg.de/en/&ei=wmvAUcX7HeGQ0QXUo4DoCw&bvm=bv.47883778,d.d2k&psig=AFQjCNGS3MY9dWHOF9OSeJOlCwmrGbJ_rg&ust=1371651388198460

38

Sirris Additive Manufacturing: Contact

© sirris 2014 Charleroi | www.sirris.be | [email protected] | CENG 04/11/2014

Grégory NOLENS, PhD

Department of Additive Manufacturing

Mail: [email protected]

Mobile: +32 498 91 94 75

Skype: gnolens

SIRRIS

Rue Auguste Piccard, 20

B-6041 GOSSELIES BELGIUM

http://www.sirris.be

« Medical Additive Manufacturing & Rapid Prototyping »

« Sirris »

Documents

SIRRIS - QED · SIRRIS Bioprinting: markets and opportunities Grégory Nolens QED –AM in Medical – November 4th 2014